儿科急症用药错误致实际伤害的多学科小组评估
该研究利用多学科小组回顾某大型儿科医院处方与给药错误数据,在566例可能致严重伤害且已触及患者的错误中确认89例实际伤害,其中轻度43%、中度48%、严重9%,无致死性伤害;抗菌药物和剂量错误最常见,给药错误致害率高于处方错误,低龄儿童风险更高。
要点
- 给药错误实际伤害率1.83%,高于处方错误的0.21%。
- 抗菌药物占伤害病例38/89,剂量错误占32/89。
- 静脉抗菌药物输注速率错误占给药致害67例中的19例。
核心结论
- 儿科用药错误中,低龄患者、错误剂量处方和静脉抗菌药物给药错误与更高实际伤害率相关。
研究设计与样本
- 回顾性药物记录审查识别处方错误(26,369条医嘱、19,692个错误、3,782名患者)。
- 前瞻性直接观察识别给药错误(5,137次给药、3,663个错误、1,530名患者)。
- 选取可能致严重伤害且已触及患者的566例病例,由多学科小组评估实际伤害及严重程度。
主要发现
- 89例确认实际伤害,其中轻度43%(38例)、中度48%(43例)、严重9%(8例),无致死性伤害。
- 伤害病例中最常见药物为抗菌药物(38/89例),最常见错误类型为剂量错误(32/89例)。
- 给药错误实际伤害率为1.83%(67/3,663),处方错误为0.21%(42/19,692)。
- 给药致害最常见类型为静脉抗菌药物输注速率错误(19/67例),其中12例发生于12月龄以下儿童。
- 低龄患者实际伤害风险显著更高(t=2.4, df=198, p=0.017),12月龄以下儿童在实际伤害病例中占更高比例(χ2(1, N=566)=10.5, p=0.001)。
临床怎么用
- 针对低龄儿童、剂量处方和静脉抗菌药物输注速率开展针对性干预以降低可预防伤害。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Medication errors continue to cause inpatient harm in children and can be difficult to both identify and classify. Medication error studies often focus on assessing potential harm and there is little published data on actual harm from medication errors in children. OBJECTIVE: Our aim was to use multidisciplinary panels to identify and describe the actual harm resulting from prescribing and administration medication errors occurring at a major paediatric hospital. METHODS: We reviewed medication error data collected from retrospective medication record reviews to identify prescribing errors (26,369 orders, 19,692 errors and 3782 patients) and prospective direct observations (5137 dose administrations, 3663 errors and 1530 patients) to identify administration errors. Errors with the potential to cause serious harm and with evidence that the error reached the patient formed the dataset for our study. Case studies (n = 566) describing the prescribing and administration errors and a brief clinical summary were reviewed by multidisciplinary panels to determine whether there was evidence in patients' records of actual harm and to rate the severity of the harm identified. RESULTS: Actual harm was identified in 89 case studies and rated as minor in 43% (n = 38), moderate in 48% (n = 43) and serious in 9% (n = 8). There were no cases of harm rated as severe resulting in death. Antibacterials were the most common medications in cases with harm (n = 38/89 cases), and dosing errors (n = 32/89) the most common error type associated with harm. Younger patients had a significantly (t = 2.4, df = 198, p = 0.017) greater risk of actual harm from medication errors, and children aged under 12 months formed a higher proportion of those with actual harm (χ2 (1, N = 566) = 10.5, p = 0.001). The most frequent type of administration errors leading to harm were wrong infusion rates of intravenous antibiotics (19/67 cases); 12 of these instances occurred in children under 12 months. Administration errors were more likely to result in actual harm (1.83%; 67 /3663 errors) compared with prescribing errors (0.21%; 42/19,692). CONCLUSIONS: We found higher rates of actual harm associated with medication errors in younger patients, wrong dose prescribing errors and intravenous antibiotic administration errors. These important findings provide opportunities for developing tailored interventions targeting identified high-risk areas to enable the successful reduction of preventable harms in paediatric patients.
引用
- Mumford V, Raban MR, Fitzpatrick E, et al. Harm to Children from Prescribing and Administration Errors in Acute Care: A Multidisciplinary Panel Assessment. Drug Saf. 2025. PMID: 41053408. doi:10.1007/s40264-025-01618-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。